STO:ADVBOX — Adventure Box Technology AB H1 2025 Financial Report Release

Annual General Meeting 2025 for Adventure Box Technology AB

Adventure Box Technology AB is set to hold its Annual General Meeting on June 30, 2025, at the Nybrogatan Business Center in Stockholm. Key agenda items include the adoption of the income statement, the proposal for a reverse share split of 1:28, and authorization for the board to issue new shares and warrants. Shareholders must register by June 19 and notify the company of their attendance by June 24. The meeting will also address board elections and proposed amendments to the Articles of Association. The outcome could have significant implications for the company's capital structure and governance.

• corp.adventurebox.com

Adventure Box Technology AB - Power of Attorney Submission Deadline

Adventure Box Technology AB has announced the deadline for shareholders to submit a power of attorney for representation at its upcoming Annual General Meeting (AGM) scheduled for June 30, 2025. Shareholders must ensure their proxies submit a written power of attorney by June 24, 2025. The meeting will address significant items including the adoption of financial statements, board elections, and a proposed reverse share split of 1:28 to enhance the share structure. The board recommends no dividend payment and intends to carry forward retained earnings. This AGM is crucial for shareholders to participate in these fundamental corporate decisions.

aXichem AB Q3 2025 Financial Report Release

aXichem AB will release its Q3 2025 financial report on November 28, 2025. The company develops nature-analog feed and dietary supplement ingredients, notably phenylcapsaicin, which has shown significant effectiveness in reducing salmonella in chicken feed in recent studies. These results support their application for EU Feed Additive approval, which is expected to enhance production efficiency in poultry farming by 14% compared to conventional feeding. The company's focus on innovative solutions in animal feed positions it favorably in the industry. aXichem is listed on the Nasdaq First North Growth Market.

aXichem AB Q2 2025 Financial Report Release

aXichem AB is set to release its Q2 2025 financial report on August 28, 2025. The company is known for developing natural analog feed and dietary supplement ingredients, primarily focusing on its product, phenylcapsaicin, which has shown statistically significant efficacy in reducing salmonella in chicken feed. This follows recent successful efficacy studies that form part of the supplementary application for EU approval of phenylcapsaicin as a feed additive aimed at enhancing poultry health. The company plans to submit additional materials to the European Food Safety Authority (EFSA) within a month following positive preliminary results, indicating potential material financial impacts depending on future regulatory approvals and market reception of their products.

Firefly AB - 2025 Annual Financial Report

Firefly AB is set to release its 2025 Annual Financial Report on February 19, 2026. The report will detail the company's performance for the fiscal year, including significant metrics such as revenue and profitability. In the previous year, Firefly recorded a 4% increase in revenue, driven by strategic improvements in operational efficiency despite facing challenges in order conversion rates due to a cautious investment climate. The board has proposed a dividend increase of 16% to 5.50 SEK per share, reflecting management's confidence in future earnings amid ongoing market uncertainties. The report will also cover key developments, including the establishment of a fully owned subsidiary in the USA and the divestment of its fire protection business in Italy, which has been structured as an asset deal effective January 1, 2025.

Jeudan A/S H1 2025 Financial Report

Jeudan A/S reported a satisfactory financial performance for the first quarter of 2025, showing revenues of DKK 443 million compared to DKK 416 million the previous year. Earnings before interest and taxes (EBIT) were DKK 268 million, slightly up from DKK 266 million in Q1 2024. The net profit increased markedly to DKK 343 million against DKK 147 million in the same quarter last year, reflecting improved operational efficiency and a positive adjustment of DKK 194 million in financial liabilities due to rising interest rates. The company maintains its EBIT forecast for 2025 at DKK 1.050-1.150 billion based on projected revenue of DKK 1.7-1.8 billion, indicating confidence amid economic uncertainties.

aXichem AB Year-End Report 2025 Release

aXichem AB is set to release its Year-End Report for 2025 on February 26, 2026. The company has reported positive results from its studies related to phenylcapsaicin, which is being developed as a feed additive to reduce salmonella in chicken feed. The final clinical study demonstrated a statistically significant effect of phenylcapsaicin in reducing salmonella, confirming its potential efficacy in enhancing animal health. aXichem plans to submit the supplementary material for EU approval to the European Food and Safety Authority (EFSA) shortly. The company specializes in synthetic substances that mimic natural compounds and is listed on the Nasdaq First North Growth Market.

Sectra AB - Financial Report Release for FY 2025

Sectra AB (STO: SECT B) will release its financial report for the fiscal year 2025 on June 5, 2025, at 08:15 CEST. Investors, analysts, and press are invited to a presentation led by CEO Torbjörn Kronander and CFO Jessica Holmquist at 10:00 CEST the same day, discussing the company's financial results, which totaled 2,964 million SEK in FY 2023/2024. Founded in 1978 and headquartered in Linköping, Sweden, Sectra specializes in medical technology and cybersecurity to enhance healthcare efficiency and safeguard sensitive information. The announcement comes as the company continues to expand its global reach and sales operations.

Autoliv Q2 2025 Financial Report Release

Autoliv Inc. will release its financial report for Q2 2025 on July 18, 2025. The company's recent Q1 2025 report highlighted net sales of $2,578 million, a 1.4% decrease year-on-year, with organic sales growth of 2.2%. Operating income rose 31% to $254 million. Despite challenges, such as geopolitical uncertainties and tariff impacts, Autoliv maintained a positive outlook for 2025 with guidance for around 2% organic growth and an adjusted operating margin of 10-10.5%.